Pubblicazioni

Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies

2020 - ANNALS OF HEMATOLOGY
Viardot, A.; Locatelli, F.; Stieglmaier, J.; Zaman, F.; Jabbour, E.

Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies

2020 - ANNALS OF HEMATOLOGY
Viardot, A.; Locatelli, F.; Stieglmaier, J.; Zaman, F.; Jabbour, E.

Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults

2020 - NEW ENGLAND JOURNAL OF MEDICINE
Foa, R.; Bassan, R.; Vitale, A.; Elia, L.; Piciocchi, A.; Puzzolo, M. -C.; Canichella, M.; Viero, P.; Ferrara, F.; Lunghi, M.; Fabbiano, F.; Bonifacio, M.; Fracchiolla, N.; Di Bartolomeo, P.; Mancino, A.; De Propris, M. -S.; Vignetti, M.; Guarini, A.; Rambaldi, A.; Chiaretti, S.

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST
Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.

National Italian Delphi panel consensus: Which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

2020 - BMC CANCER
Lussana, F.; Minetto, P.; Ferrara, F.; Chiaretti, S.; Specchia, G.; Bassan, R.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma